Neil Brewis
Amministratore Delegato presso F-STAR THERAPEUTICS, INC.
Posizioni attive di Neil Brewis
Società | Posizione | Inizio | Fine |
---|---|---|---|
F-STAR THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 08/03/2023 | - |
Amministratore Delegato | - | - | |
Direttore Tecnico/Scientifico/R&S | 20/11/2020 | - | |
F-star Alpha Ltd.
F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | 02/11/2015 | - |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Neil Brewis
Precedenti posizioni note di Neil Brewis
Società | Posizione | Inizio | Fine |
---|---|---|---|
GSK PLC | Corporate Officer/Principal | 01/01/2007 | 01/10/2015 |
Domantis Ltd.
Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | 01/01/2002 | 01/01/2007 |
SPRING BANK PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 20/11/2020 | - |
Formazione di Neil Brewis
University Of Dundee | Doctorate Degree |
University of Hertfordshire | Undergraduate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 7 |
Austria | 2 |
Stati Uniti | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 4 |
Director/Board Member | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
GSK PLC | Health Technology |
Aziende private | 5 |
---|---|
F-star Alpha Ltd.
F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
F-Star Therapeutics, Inc. (United States)
F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology F-Star Therapeutics, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA. | Health Technology |
F-star Therapeutics, Inc.
F-star Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Domantis Ltd.
Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | Health Technology |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Neil Brewis
- Esperienza